₪
0.38
Nov 27
Business Description
Clal Biotechnology Industries Ltd
ISIN : IL0011042806
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 0.58 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -9.09 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 86.7 | |||||
3-Year FCF Growth Rate | 37.9 | |||||
3-Year Book Growth Rate | -30.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.68 | |||||
9-Day RSI | 61.05 | |||||
14-Day RSI | 53.21 | |||||
6-1 Month Momentum % | -14.99 | |||||
12-1 Month Momentum % | -7.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 2.18 | |||||
Cash Ratio | 2.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -14.09 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -25396.88 | |||||
Net Margin % | -233553.13 | |||||
FCF Margin % | -25159.38 | |||||
ROE % | -76.36 | |||||
ROA % | -48.67 | |||||
ROIC % | -5.65 | |||||
ROC (Joel Greenblatt) % | 1070.24 | |||||
ROCE % | 26.69 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 378.14 | |||||
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 0.99 | |||||
EV-to-EBIT | 1.83 | |||||
EV-to-EBITDA | 1.81 | |||||
EV-to-Revenue | 2267.72 | |||||
EV-to-FCF | -8.51 | |||||
Price-to-Median-PS-Value | 18.8 | |||||
Earnings Yield (Greenblatt) % | 54.56 | |||||
FCF Yield % | -13.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clal Biotechnology Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 0.032 | ||
EPS (TTM) (₪) | -0.48 | ||
Beta | 0 | ||
Volatility % | 46.15 | ||
14-Day RSI | 53.21 | ||
14-Day ATR (₪) | 0.012263 | ||
20-Day SMA (₪) | 0.36475 | ||
12-1 Month Momentum % | -7.89 | ||
52-Week Range (₪) | 0.29 - 0.53 | ||
Shares Outstanding (Mil) | 156.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clal Biotechnology Industries Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clal Biotechnology Industries Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Clal Biotechnology Industries Ltd Frequently Asked Questions
What is Clal Biotechnology Industries Ltd(XTAE:CBI)'s stock price today?
When is next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI)?
Does Clal Biotechnology Industries Ltd(XTAE:CBI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |